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'"AMBIQUITOUS" BEHAVIOR OF BRAIN HEXOKINASE
RAPID AND REVERSIBLE INTERACTION OF HEXOKINASE WITH THE
OUTER MITOCHONDRIAL MEMBRANE
J. E. WILSON
Biochemistry Department, Michigan State University, East Lansing, Michigan 48824, U.S.A.
Certain enzymes exhibit rapidly reversible associations
with subcellular structures. These enzymes have been
called "ambiquitous" (both places; cf., "ubiquitous," all
places) to emphasize that their intracellular location may
be variable, being a function of metabolic status in the cell
(1). The most thoroughly studied ambiquitous enzyme is
brain hexokinase (ATP: D-hexose 6-phosphotransferase,
EC 2.7.1.1) (2). Hexokinase binds reversibly and specifi-
cally to the outer mitochondrial membrane, with the
binding equilibrium being sensitive to physiologically rele-
vant metabolites such as ATP and glucose-6-P. Variations
in distribution of the enzyme between bound and solubi-
lized forms are believed to be involved in regulation of
catalytic activity, the bound form of the enzyme being
more active. Variation in the soluble:particulate distribu-
tion of hexokinase has been reported to occur in response
to in vivo perturbations of normal cerebral energy meta-
bolism with increased proportion of mitochondrially bound
enzyme found during periods of increased glycolytic rate
(e.g., 3, 4).
Ambiquitous behavior has two fundamental require-
ments: there must be complementary recognition signals
on enzyme and membrane which permit specific interac-
tion; and there must be some mechanism by which the
strength of that interaction can be modulated by parame-
ters reflecting metabolic status of the cell. Current efforts
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FIGURE 1 Speculative model representing interaction of brain hexokinase with the outer mitochondrial membrane. The enzyme is pictured
as having two functional domains: one, enclosed by dashed circle, includes the C-terminus (arbitrarily) and the catalytic site; the other
includes the N-terminal region and is responsible for interaction with the membrane. The N-terminal segment, led by the hydrophobic triplet,
Tyr-Tyr-Phe, is inserted into the membrane and interacts with the hexokinase binding protein (crosshatched rectangle) in the membrane.
Additional divalent cation-mediated interactions also occur (6). As a result of binding glucose-6-P (small stippled rectangle), the enzyme
undergoes a conformational change which results in retraction of the N-terminal segment from the membrane (and also causes inhibition of
catalytic activity). The enzyme is now bound less tightly, with only the divalent cation-mediated forces operational, i.e., the binding
equilibrium is shifted toward increased amounts of "solubilized" enzyme. In the presence of 1 mM Mg"+ the association of enzyme with the
membrane can largely be maintained even in the presence of glucose-6-P. Since the intracellular concentration of Mg"+ has been estimated
at -1 mM (7), it may be that, in vivo, the reversible interactions between hexokinase and the outer mitochondrial membrane are primarily
restricted to the glucose-6-P sensitive states shown at the left of the figure, i.e., between tightly bound (N-terminal inserted) and loosely
bound (N-terminal retracted) states. (Reprinted, with permission of Academic Press, from reference 2).
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in our laboratory are directed at determining how these
fundamental requirements are fulfilled in the hexokinase-
outer mitochondrial membrane system.
RESULTS
A "hexokinase binding protein" (HBP) has been highly
purified from outer mitochondrial membranes by a proce-
dure involving dissociation of the membrane with octyl
glucoside followed by reconstitution of lipid vesicles into
which the HBP is selectively incorporated (5). Based on its
inaccessibility to exogenous proteases, the HBP (subunit
mol wt, 31,000) is thought to be an integral protein of the
outer mitochondrial membrane. This protein appears to be
the sole membrane component responsible for specific
interaction with hexokinase. Indirect evidence suggested
involvement of the N-terminal region of the enzyme in the
binding. The N-terminal amino acid sequence has now
been determined. The first three residues are a triplet of
aromatic amino acids, Tyr-Tyr-Phe. This unusually hydro-
phobic sequence may provide a "wedge" by which the
N-terminal portion of the enzyme secures access to the
HBP buried in the membrane. A speculative model for the
hexokinase-membrane interaction is shown in the accom-
panying figure.
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THE MEMBRANE ENZYME COMPLEX REQUIRED FOR L-
PROLINE TRANSPORT AND UTILIZATION IN
ESCHERICHIA COLI K12
JANET M. WOOD
Guelph-Waterloo Centrefor Graduate Work in Chemistry, University ofGuelph, Guelph, Ontario NJ G
2WI, Canada
L-proline is actively accumulated by Escherichia coli K12
and can be oxidized to L-glutamate, serving as sole carbon
and/or nitrogen source for bacterial growth. Two specific
transport systems, denoted proline porters I and II (PP-I
and PP-Il), catalyze proline uptake (1).' Proline oxidation
to A'-pyrroline carboxylate is coupled via the respiratory
chain with the reduction of 02 (2). The membrane-
associated enzyme proline dehydrogenase catalyzes that
reaction and probably also the NAD+-linked oxidation of
A'-pyrroline carboxylate to glutamate (2, 3). Proline dehy-
drogenase is encoded in the putA gene and mutations at
the adjacent locus, putP, inactivate PP-I (1). Although
putP and putA are transcribed separately, their expression
is controlled coordinately by catabolite repression and
specific induction (1, 3). In addition to its enzymatic
'Stalmach, M. and J. M. Wood. Unpublished results.
TABLE I
ESCHERICHIA COLI K12 STRAINS
Gene dosage4
Strain* Genotype*
putP putA
CSH4 F- trp lacZ rpsL thi 1 1
RM2 CSH4 AputPAIOO 0 0
JT31 CSH4 putAl::Tn5 1 0
JT34 CSH4 putP3::Tn5 0 1
WG2400 RM2 recA srl::TnJO 0 0
WG2404 WG2400/pLC35-38 >1§ 0
WG2405 WG2400/pLC43-41 >1 >1
WG2406 WG2400/ColE1 0 0
*The derivation of these strains and genetic nomenclature have been
described (1, 4).
tGene dosages are given as numbers of copies of the intact gene per
chromosome.
§Although pLC35-38 complements putP defects, the plasmid insert has
not been shown conclusively to include putP (4).
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